@Jerome_Larche @institutpasteur @aur_rousseau @hcsp_fr @raoult_didier @AnneliseBocquet Et voici l'article scientifique correspondant au témoignage ci-dessus.
Efficacy of early hydroxychloroquine treatment in preventing COVID-19 pneumonia aggravation, the experience from Shanghai, China.
Yi Su, ... , Bijie Hu
https://t.co/8KpFaBXa8t
@JimDoubleYou1 @fluidloading Efficacy of early hydroxychloroquine treatment in preventing COVID-19 pneumonia aggravation, the experience from Shanghai, China
(Reçu le 27 sept 2020)
https://t.co/VNi09kQvmT
@GidMK @LoLoWarn @ImyJohnson35 "The early use of hydroxychloroquine was a protective factor associated with disease aggravation. Clinical improvement by 20 days was significantly different between patients with hydroxychloroquine used early and those with hydroxychloroquine not used."
https://t.co/VNi09kPXxl
Efficacy of early hydroxychloroquine treatment
https://t.co/VNi09kQvmT
Il faut comparer ce qui est comparable (etudes en usage précoce)
& arrêter de se référer aux etudes Recovery/Discovery/Solidarity qui ont "tué" la HCQ... au prix de quelles vies ?!
@ansm @hcsp_fr @acadmed https://t.co/dMBVfcB8pW
@think_fungus @C_A_Gustave 2/2
Malheureusement, s'il n'y pas de médecine de ville et que les hopitaux sont débordés...
Efficacy of early hydroxychloroquine treatment in preventing COVID-19 pneumonia aggravation, the experience from Shanghai, China
https://t.co/VNi09kPXxl
"Individuals with low circulating oxytocin levels coupled with low HMW APN levels were at significantly increased risk of MetS. The combination of both markers would be useful for identifying MetS high risk patients".
https://t.co/cXJuBAOvb3 https://t.co/OX20QIgYtC
@Jean_no Résumé en anglais du consensus chinois.
Montrez le aux médecins et demandez leur d'interroger l'ordre des médecins sur sa position actuelle
https://t.co/STHHV6y2Pa
@ordre_medecins @LeGene_hebdo @leQdM @WhatsUpDoc_mag @EgoraInfo @afpfr @lemonde_sante @LeFigaro_Sante @CDOM42 @CDOM63INFO @CDOmedecins94 @EPhilippePM @raoult_didier Justement, on trouve dans cet article la conclusion positive d'études cliniques que la HAS attendait (citées dans son rapport du 5 mars).
https://t.co/CGo6pTuNon
#Hydroxycloroquine
#COVID19
#Corona
#coronavirus
@EmmanuelMacron
@Conseil_Etat
@pdousteblazy
https://t.co/9px2n3uHlB https://t.co/4gkoccLoZK
@mormach @alexis5767 @Conseil_Etat @EmmanuelMacron @HAS_sante @acadmed @MinSoliSante @EPhilippePM En voici un cité par le center disease control (usa) :
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
https://t.co/CGo6pTuNon